Research resource
A plain-English 2026 guide to the UK regulatory framework for research-grade peptides. Covers the Misuse of Drugs Act 1971, the MHRA distinction between medicines and research reagents, the Human Medicines Regulations 2012, and how UK research-supply (including from this site) operates lawfully. Educational summary - not legal advice. For specific questions consult a qualified UK legal adviser.
Yes - research-grade peptides supplied for in-vitro laboratory and research use only, that are not classified as controlled substances under the Misuse of Drugs Act 1971, can lawfully be sold and possessed in the UK. The legal distinction that matters is the one between medicines (which require MHRA marketing authorisation) and research reagents (which do not, provided no therapeutic claims are made and they are not sold for human consumption).
Black & White Peptides Ltd supplies all compounds strictly as research reagents. We do not make therapeutic claims, do not provide dosing advice for humans, and do not market our products as medicines. Every product page on this site carries this framing explicitly.
This is the UK statute that classifies controlled substances (Class A, B, C). None of the compounds in our catalogue are classified as controlled substances under the Misuse of Drugs Act. Synthetic peptides such as Tirzepatide, Semaglutide, BPC-157, GHK-Cu and the GHRH analogues are research-grade reference compounds, not controlled drugs.
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines for human use. To sell a substance as a medicine in the UK, the supplier needs a marketing authorisation from the MHRA. Without one, the substance cannot be marketed for therapeutic use.
Crucially, the MHRA framework distinguishes between marketing a substance for therapeutic use (regulated, requires authorisation) and supplying a substance as a research reagent without therapeutic claims (not regulated under the medicines framework, treated like any other research chemical). The key test is what is claimed at the point of sale.
The "Research Use Only" disclaimer is not a marketing slogan - it is the legal frame within which research-grade compounds are supplied lawfully without an MHRA medicines authorisation. Specifically:
This is the same framing used by mainstream research-chemical suppliers like Sigma-Aldrich (now Merck), Cayman Chemical, Tocris Bioscience, and Bachem. Buyers of research compounds from those companies are not buying medicines - they are buying laboratory reagents.
Research-grade peptides for in-vitro work are legal to purchase and possess. Standard laboratory practice applies: store appropriately, label clearly, follow your institution's chemical-handling protocols. No personal licence is required for the compounds in our catalogue.
UK-domestic supply (such as from this site) avoids the customs/labelling questions that arise when importing research compounds from outside the UK or EU. Black & White Peptides Ltd is registered in England & Wales (company number 16876162). Bulk and academic procurement is handled via the Wholesale page.
Yes - provided they are not controlled substances under the Misuse of Drugs Act 1971, and provided they are supplied as research reagents (not as medicines). All compounds we supply meet these conditions.
None of the compounds in our catalogue are controlled substances under the Misuse of Drugs Act 1971. They are research reference reagents.
No special licence is required for the compounds in our catalogue when supplied for in-vitro research use only. The same is true of any other research-grade chemical from suppliers like Sigma-Aldrich, Tocris, or Cayman Chemical.
Because that is what they are. To be sold as medicines they would need MHRA marketing authorisation. We supply them as research reagents only - no therapeutic claims, no human dosing, not for human or veterinary consumption.
Importing for personal use raises customs and labelling questions that vary by source country. UK-domestic supply - such as from this site - sidesteps those issues for UK researchers.
This page is an educational summary and does not constitute legal advice. For specific legal questions about your research procurement, consult a qualified UK legal adviser. Black & White Peptides Ltd is registered in England & Wales, company number 16876162.